Abstract
Lung cancer is the leading cause of cancer-related deaths mainly attributable to metastasis, especially extrathoracic metastasis. This large-cohort research is aimed to explore metastatic profiles in different histological types of lung cancer, as well as to assess clinicopathological and survival significance of diverse metastatic lesions. Lung cancer cases were extracted and enrolled from the Surveillance, Epidemiology, and End Results (SEER) database. χ2-tests were conducted to make comparisons of metastatic distribution among different histological types and odds ratios were calculated to analyze co-occurrence relationships between different metastatic lesions. Kaplan-Meier methods were performed to analyze survival outcomes according to different metastatic sites and Cox regression models were conducted to identify independent prognostic factors. In total, we included 159,241 lung cancer cases with detailed metastatic status and complete follow-up information. In order to understand their metastatic patterns, we elucidated the following points in this research: (1) Comparing the frequencies of different metastatic lesions in different histological types. The frequency of bone metastasis was highest in adenocarcinoma, squam...Continue Reading
References
May 14, 2011·Lancet·Jan P van MeerbeeckDirk K M De Ruysscher
May 14, 2011·Lancet·Peter GoldstrawFrances A Shepherd
Dec 4, 2012·Oncology Letters·Kensuke NakazawaNobuyuki Hizawa
Mar 19, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Julio Sánchez de Cos EscuínHelena Hernández Rodríguez
Jul 22, 2014·Clinical Lung Cancer·Yan-yan HeYi-long Wu
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Oct 23, 2014·Cancer·Lauren Averett Byers, Charles M Rudin
May 31, 2015·Clinics in Chest Medicine·Patricia M de GrootJeremy J Erasmus
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M RudinGiuseppe Giaccone
Nov 5, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Wilfried E E EberhardtUNKNOWN International Association for Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Par
Jan 15, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Particip
Mar 26, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anne S TsaoHarvey I Pass
Aug 19, 2016·Cancer Treatment and Research·Jaime Rodriguez-CanalesIgnacio I Wistuba
Aug 19, 2016·Cancer Treatment and Research·Gavitt A WoodardDavid M Jablons
Aug 31, 2016·Lancet·Fred R HirschLuis Paz-Ares
Aug 9, 2017·Clinical Pharmacology and Therapeutics·Manasi K Mayekar, Trever G Bivona
Aug 26, 2017·Journal of Thoracic Disease·James E Bates, Michael T Milano
Jan 24, 2018·Future Oncology·Hongchao CaiJinming Yu
Apr 7, 2018·Radiologic Clinics of North America·Girish S ShroffBradley S Sabloff
Jun 9, 2018·Frontiers in Oncology·Federica FranchinoRiccardo Soffietti
Oct 3, 2018·Japanese Journal of Clinical Oncology·Aritoshi HattoriKenji Suzuki
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Citations
Feb 4, 2021·Thoracic Cancer·Zsolt MegyesfalviBalazs Dome
Mar 13, 2021·Future Oncology·Haizhen ZhuQiao Yang
Jul 31, 2021·OncoTargets and Therapy·Bo ZhangYun Zhang